• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    (OP:ONNVF)

    0.4309 -0.0080 (-1.82%)
    Streaming Delayed Price Updated: 9:30 AM EDT, Aug 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about ONNVF

    < Previous 1 2 3 4 Next >
    NetworkNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) Combines Targeted Cancer Therapy, Nanotechnology and AI
    Via Investor Brand Network
    Topics Artificial Intelligence
    BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Closes CAD$5 Million Private Placement to Advance Oncology Programs
    Via Investor Brand Network
    BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) Moves Lead Oncology Candidate Toward Future Clinical Studies
    Via Investor Brand Network
    Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF): Combining Three Emerging Frontiers in Cancer Drug Development
    Via Investor Brand Network
    Topics Artificial Intelligence
    Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) Advances Precision Oncology as Biomarker-Driven Cancer Gains Momentum
    Via Investor Brand Network
    BioMedNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Completes Analytical Reference Standard Program for ONC010
    Via Investor Brand Network
    Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF): Cancer Nanomedicine Enters a New Generation
    Via Investor Brand Network
    News headline image
    Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API
    From Onco-Innovations Limited
    Via ACCESS Newswire
    InvestorNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Announces Term Sheet for CAD$5 Million Private Placement
    Via Investor Brand Network
    NetworkNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advances ONC010 Manufacturing Development With Nanosoft
    Via Investor Brand Network
    News headline image
    Onco-Innovations Announces Term Sheet for Notional CAD$5 Million Performance-Based Funding Arrangement and Amendments to Previously Announced Financing
    From Onco-Innovations Limited
    Via ACCESS Newswire
    News headline image
    Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010
    From Onco-Innovations Limited
    Via ACCESS Newswire
    Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) Advances Manufacturing and Development Efforts as It Pursues a Novel Approach to Hard-to-Treat Cancers
    Via Investor Brand Network
    News headline image
    Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
    From Onco-Innovations Limited
    Via ACCESS Newswire
    NetworkNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in NetworkNewsAudio Editorial on DNA Repair Therapies
    Via Investor Brand Network
    News headline image
    NetworkNewsAudio Announces Audio Press Release (APR) Discussing the Development of PNKP Inhibitors in Oncology Drug Development
    From NetworkNewsWire
    Via GlobeNewswire
    News headline image
    InvestorNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in BioMedWire Editorial on Emerging DNA Repair Inhibitors
    Via Investor Brand Network
    News headline image
    Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes
    From Onco-Innovations Limited
    Via GlobeNewswire
    Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
    Via Investor Brand Network
    BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Targets Next Generation of DNA Damage Response Cancer Therapies
    Via Investor Brand Network
    Topics Artificial Intelligence
    InvestorNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Engages Nanosoft to Advance ONC010 Development Program
    Via Investor Brand Network
    News headline image
    Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
    From BioMedWire
    Via GlobeNewswire
    News headline image
    Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
    From Onco-Innovations Limited
    Via ACCESS Newswire
    BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in BioMedWire Editorial on DNA Repair Cancer Therapies
    Via Investor Brand Network
    News headline image
    Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advancing Nanoparticle-Encapsulated PNKP Inhibitor in Oncology Space
    From Onco-Innovations Limited
    Via GlobeNewswire
    BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Targets Next Wave of DNA Damage Response Cancer Therapies
    Via Investor Brand Network
    Topics Artificial Intelligence
    Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
    Via Investor Brand Network
    NetworkNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Announces C$5 Million Private Placement to Advance ONC010 Development
    Via Investor Brand Network
    BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Advances ONC010 Program With Successful 300-Gram API Scale-Up Batch
    Via Investor Brand Network
    News headline image
    Onco-Innovations Announces Non-Brokered LIFE Offering
    From Onco-Innovations Limited
    Via ACCESS Newswire
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.